NCCTG phase I trial of Everolimus (RAD001) and Temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients (N057K).
- Citation:
- Mol Cancer Ther vol 8 (12s) abstr C56
- Meeting Instance:
- EORTC-NCI-AACR 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. N. Sarkaria E. Galanis P. J. Peller P. D. Brown W. Wu S. J. Felten J. H. Uhm C. Giannini K. A. Jaeckle J. C. Buckner
- Networks:
- Study
- NCCTG-N057K
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1,2
- Keywords: